116 related articles for article (PubMed ID: 1949812)
21. The utility of detecting of autoantibodies against neutrophil cytoplasmic components in Wegener's granulomatosis.
Chng HH; Ganz T; Saxon A
Ann Allergy; 1989 Nov; 63(5):411-6. PubMed ID: 2817531
[TBL] [Abstract][Full Text] [Related]
22. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
Grotz W; Wanner C; Keller E; Böhler J; Peter HH; Rohrbach R; Schollmeyer P
Clin Nephrol; 1991 Jun; 35(6):243-51. PubMed ID: 1873937
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
25. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
26. Wegener's granulomatosis in a pediatric patient.
Kinn MC; Dowell M;
J Okla State Med Assoc; 2004 Jan; 97(1):36-8; quiz 39-41. PubMed ID: 14998066
[TBL] [Abstract][Full Text] [Related]
27. Wegener's granulomatosis in a pediatric patient.
Kinn MC; Dowell M
J Okla State Med Assoc; 2003 Dec; 96(12):563-5; quiz 566-8. PubMed ID: 14965025
[TBL] [Abstract][Full Text] [Related]
28. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
Holle JU; Gross WL; Holl-Ulrich K; Ambrosch P; Noelle B; Both M; Csernok E; Moosig F; Schinke S; Reinhold-Keller E
Ann Rheum Dis; 2010 Nov; 69(11):1934-9. PubMed ID: 20511614
[TBL] [Abstract][Full Text] [Related]
29. Renal disease associated with circulating antineutrophil cytoplasm activity.
Garrett PJ; Dewhurst AG; Morgan LS; Mason JC; Dathan JR
Q J Med; 1992 Oct; 85(306):731-49. PubMed ID: 1287705
[TBL] [Abstract][Full Text] [Related]
30. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.
Hind CR; Winearls CG; Lockwood CM; Rees AJ; Pepys MB
Clin Nephrol; 1984 Jun; 21(6):341-5. PubMed ID: 6467689
[TBL] [Abstract][Full Text] [Related]
31. [Wegener's granulomatosis and autoantibodies against cytoplasmic granules of neutrophils].
Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1988 Aug; 118(33):1163-8. PubMed ID: 3175567
[TBL] [Abstract][Full Text] [Related]
32. ANCA in haemodialysis patients.
Weidemann S; Andrassy K; Ritz E
Nephrol Dial Transplant; 1993; 8(9):839-45. PubMed ID: 8255517
[TBL] [Abstract][Full Text] [Related]
33. Difficulty of diagnosing Wegener's granulomatosis in the head and neck region.
Tsuzuki K; Fukazawa K; Takebayashi H; Hashimoto K; Sakagami M
Auris Nasus Larynx; 2009 Feb; 36(1):64-70. PubMed ID: 18479857
[TBL] [Abstract][Full Text] [Related]
34. Anti-neutrophil cytoplasmic antibodies (ANCA): a seromarker for Wegener's granulomatosis.
Turner A
J Otolaryngol; 1991 Aug; 20(4):274-5. PubMed ID: 1920582
[TBL] [Abstract][Full Text] [Related]
35. [A case of limited form of Wegener's granulomatosis associated with persistent high titer of serum antineutrophil cytoplasmic antibodies].
Akamatsu A; Yamauchi M; Ikeda Y; Yoshida M
Ryumachi; 1992 Feb; 32(1):52-7. PubMed ID: 1604417
[TBL] [Abstract][Full Text] [Related]
36. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
37. Wegener's granulomatosis.
Yi ES; Colby TV
Semin Diagn Pathol; 2001 Feb; 18(1):34-46. PubMed ID: 11296992
[TBL] [Abstract][Full Text] [Related]
38. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
39. Wegener's granulomatosis in northern India.
Singh YN; Malaviya AN; Sharma SK; Kumar A; Wali JP; Dash SC; Bhuyan UN
J Assoc Physicians India; 1992 Sep; 40(9):594-6. PubMed ID: 1308014
[TBL] [Abstract][Full Text] [Related]
40. Management and follow-up of localized Wegener's granulomatosis: a review of five cases.
Nishiike S; Kato T; Nagai M; Konishi M; Sakata Y
Acta Otolaryngol; 2004 Nov; 124(9):1103-8. PubMed ID: 15513558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
